Exercise and creatine combo may restore strength in cancer survivors
NCT ID NCT06420726
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
Many colorectal cancer survivors lose muscle mass and strength after chemotherapy. This study tested whether adding creatine supplements to a 10-week resistance training program could help. Twenty-seven survivors participated, comparing those who took creatine with those who only exercised. The goal was to see if this combination is feasible and acceptable, and whether it improves muscle strength, physical function, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- creatine monohydrate
- What this could lead to
- If this approach works, it could offer a simple way to help colorectal cancer survivors rebuild muscle strength and physical function after chemotherapy.
- What could go wrong
- This is a small pilot study with only 27 participants, so results may not apply to everyone. The combination of exercise and supplements may not provide additional benefit over exercise alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of South Carolina
Columbia, South Carolina, 29201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?